| 1 |
35460397 | First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer. | 2022 Apr 17 |
1 |
| 2 |
33720069 | Changes in the therapeutic landscape of oesophago-gastric cancers. | 2021 Jul 1 |
1 |
| 3 |
27626067 | Testing ERBB2 p.L755S kinase domain mutation as a druggable target in a patient with advanced colorectal cancer. | 2016 Sep |
1 |
| 4 |
23007148 | Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 cases. | 2012 |
1 |
| 5 |
21985855 | Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T). | 2011 |
1 |
| 6 |
15640503 | Prognostic implications of the expression of erbB2, topoisomerase II alpha and thymidylate synthase in metastatic gastric cancer after fluorouracil-based therapy. | 2004 Dec |
1 |